Regarding JV or BuyOut Speculation-Teva announced it will try to sell a line of their women's health business for 2 billion in an effort to reduce debt. Not sure if this is also to free up funds for a JV. Not sure that OWCP would value themselves that low even being pre-revenue and needing to go through clinical trials for prescription based products. Don't have the link but saw on Bloomburg this morning.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links